Generics Global Group of Eight (G8) Industry Guide 2019-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,495	282 Pages	MarketLine	December, 2024	MTLN19599833

Best Price Guarantee
Price	from $1,495
Length	282 Pages
Publisher	MarketLine
Published Date	December, 2024
SKU	MTLN19599833

Generics Global Group of Eight (G8) Industry Guide 2019-2028Summary

The G8 Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume , and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

The G8 countries contributed $1,61,715.9 million in 2023 to the global generics industry, with a compound annual growth rate (CAGR) of 5.8% between 2019 and 2023. The G8 countries are expected to reach a value of $2,15,698.2 million in 2028, with a CAGR of 5.9% over the 2023-28 period.
Among the G8 nations, the US is the leading country in the generics industry, with market revenues of $74,229.0 million in 2023. This was followed by Germany and the UK, with a value of $27,662.3 and $15,516.9 million, respectively.
The US is expected to lead the generics industry in the G8 nations with a value of $98,531.3 million in 2016, followed by Germany and the UK with expected values of $33,345.6 and $23,397.0 million, respectively.

Scope

Save time carrying out entry-level research by identifying the size, growth, and leading players in the G8 generics market
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 generics market
Leading company profiles reveal details of key generics market players’ G8 operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the G8 generics market with five year forecasts by both value and volume
Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country

Reasons to Buy

What was the size of the G8 generics market by value in 2023?
What will be the size of the G8 generics market in 2028?
What factors are affecting the strength of competition in the G8 generics market?
How has the market performed over the last five years?
How large is the G8 generics market in relation to its regional counterparts?

1 Introduction: 1.1. What is this report about?; 1.2. Who is the target reader?; 1.3. How to use this report; 1.4. Definitions
2 Group of Eight (G8) Generics: 2.1. Industry Outlook
3 Generics in Canada: 3.1. Market Overview; 3.2. Market Data; 3.3. Market Segmentation; 3.4. Market outlook; 3.5. Five forces analysis
4 Macroeconomic Indicators: 4.1. Country data
5 Generics in France: 5.1. Market Overview; 5.2. Market Data; 5.3. Market Segmentation; 5.4. Market outlook; 5.5. Five forces analysis
6 Macroeconomic Indicators: 6.1. Country data
7 Generics in Germany: 7.1. Market Overview; 7.2. Market Data; 7.3. Market Segmentation; 7.4. Market outlook; 7.5. Five forces analysis
8 Macroeconomic Indicators: 8.1. Country data
9 Generics in Italy: 9.1. Market Overview; 9.2. Market Data; 9.3. Market Segmentation; 9.4. Market outlook; 9.5. Five forces analysis
10 Macroeconomic Indicators: 10.1. Country data
11 Generics in Japan: 11.1. Market Overview; 11.2. Market Data; 11.3. Market Segmentation; 11.4. Market outlook; 11.5. Five forces analysis
12 Macroeconomic Indicators: 12.1. Country data
13 Generics in Russia: 13.1. Market Overview; 13.2. Market Data; 13.3. Market Segmentation; 13.4. Market outlook; 13.5. Five forces analysis
14 Macroeconomic Indicators: 14.1. Country data
15 Generics in The United Kingdom: 15.1. Market Overview; 15.2. Market Data; 15.3. Market Segmentation; 15.4. Market outlook; 15.5. Five forces analysis
16 Macroeconomic Indicators: 16.1. Country data
17 Generics in The United States: 17.1. Market Overview; 17.2. Market Data; 17.3. Market Segmentation; 17.4. Market outlook; 17.5. Five forces analysis
18 Macroeconomic Indicators: 18.1. Country data
19 Company Profiles: 19.1. Teva Pharmaceutical Industries Ltd; 19.2. Viatris Inc; 19.3. Sun Pharmaceutical Industries Ltd; 19.4. Novartis AG; 19.5. Sandoz Group AG; 19.6. Hikma Pharmaceuticals Plc; 19.7. Sanofi; 19.8. Les Laboratoires Servier SAS; 19.9. Stada Arzneimittel AG; 19.10. Bayer AG; 19.11. Lupin Ltd; 19.12. Aspen Pharmacare Holdings Ltd; 19.13. EMS SA; 19.14. Eurofarma Laboratorios SA; 19.15. Ache Laboratorios Farmaceuticos SA; 19.16. Apotex Inc; 19.17. Teva Canada Ltd; 19.18. Sandoz Canada Inc; 19.19. CSPC Pharmaceutical Group Ltd; 19.20. Sino Biopharmaceutical Ltd; 19.21. Hansoh Pharmaceutical Group Co Ltd; 19.22. Dr. Reddy's Laboratories Ltd; 19.23. Cipla Ltd; 19.24. Aurobindo Pharma Ltd; 19.25. PT Kalbe Farma Tbk; 19.26. PT Indofarma Tbk; 19.27. PT Sanbe Farma; 19.28. PT Soho Global Health Tbk; 19.29. Friulchem SpA; 19.30. DOC Generici SRL; 19.31. Recordati SpA; 19.32. Daiichi Sankyo Co Ltd; 19.33. Towa Pharmaceutical Co Ltd; 19.34. Sawai Group Holdings Co Ltd; 19.35. Toho Holdings Co Ltd; 19.36. Laboratorios Silanes SA de CV; 19.37. Pfizer Inc; 19.38. Biocad; 19.39. R-Pharm; 19.40. Pharmstandard; 19.41. AstraZeneca Plc; 19.42. Bluefish Pharmaceuticals AB; 19.43. Navamedic ASA; 19.44. Novartis International AG; 19.45. Beacons Pharmaceuticals Pte Ltd; 19.46. Abbott Laboratories SA; 19.47. Adcock Ingram Holdings Ltd; 19.48. Dongkook Pharmaceutical Co Ltd; 19.49. JW Holdings Corp; 19.50. Hanmi Pharmaceuticals Co Ltd; 19.51. Dong Wha Pharma Co Ltd; 19.52. Esteve Pharmaceuticals SA; 19.53. Abdi Ibrahim Ilac Sanayi ve Ticaret AS; 19.54. Deva Holding AS; 19.55. Sandoz Inc
20 Appendix: 20.1. Methodology; 20.2. About MarketLine
List of Tables: Table 1: G8 generics industry, revenue($m), 2019-28; Table 2: G8 generics industry, revenue by country ($m), 2019-23; Table 3: G8 generics industry forecast, revenue by country ($m), 2023-28; Table 4: Canada generics market value: $ million, 2018-23; Table 5: Canada generics market volume: % of total pharma volume, 2018-23; Table 6: Canada generics market geography segmentation: $ million, 2023; Table 7: Canada generics market value forecast: $ million, 2023-28; Table 8: Canada generics market volume forecast: % of total pharma volume, 2023-28; Table 9: Canada Size of Population (million), 2019-23; Table 10: Canada real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 11: Canada GDP (Current Prices, $ Billion), 2019-23; Table 12: Canada Inflation, 2019-23; Table 13: Canada Consumer Price Index (Absolute), 2019-23; Table 14: Canada exchange rate, 2018-23; Table 15: France generics market value: $ million, 2018-23; Table 16: France generics market volume: % of total pharma volume, 2018-23; Table 17: France generics market geography segmentation: $ million, 2023; Table 18: France generics market value forecast: $ million, 2023-28; Table 19: France generics market volume forecast: % of total pharma volume, 2023-28; Table 20: France Size of Population (million), 2019-23; Table 21: France real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 22: France GDP (Current Prices, $ Billion), 2019-23; Table 23: France Inflation, 2019-23; Table 24: France Consumer Price Index (Absolute), 2019-23; Table 25: France exchange rate, 2018-23; Table 26: Germany generics market value: $ million, 2018-23; Table 27: Germany generics market volume: % of total pharma volume, 2018-23; Table 28: Germany generics market geography segmentation: $ million, 2023; Table 29: Germany generics market value forecast: $ million, 2023-28; Table 30: Germany generics market volume forecast: % of total pharma volume, 2023-28; Table 31: Germany Size of Population (million), 2019-23; Table 32: Germany real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 33: Germany GDP (Current Prices, $ Billion), 2019-23; Table 34: Germany Inflation, 2019-23; Table 35: Germany Consumer Price Index (Absolute), 2019-23; Table 36: Germany exchange rate, 2018-23; Table 37: Italy generics market value: $ million, 2018-23; Table 38: Italy generics market volume: % of total pharma volume, 2018-23; Table 39: Italy generics market geography segmentation: $ million, 2023; Table 40: Italy generics market value forecast: $ million, 2023-28; Table 41: Italy generics market volume forecast: % of total pharma volume, 2023-28; Table 42: Italy Size of Population (million), 2019-23; Table 43: Italy real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 44: Italy GDP (Current Prices, $ Billion), 2019-23; Table 45: Italy Inflation, 2019-23; Table 46: Italy Consumer Price Index (Absolute), 2019-23; Table 47: Italy exchange rate, 2018-23; Table 48: Japan generics market value: $ million, 2018-23; Table 49: Japan generics market volume: % of total pharma volume, 2018-23; Table 50: Japan generics market geography segmentation: $ million, 2023; Table 51: Japan generics market value forecast: $ million, 2023-28; Table 52: Japan generics market volume forecast: % of total pharma volume, 2023-28; Table 53: Japan Size of Population (million), 2019-23; Table 54: Japan real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 55: Japan GDP (Current Prices, $ Billion), 2019-23; Table 56: Japan Inflation, 2019-23; Table 57: Japan Consumer Price Index (Absolute), 2019-23; Table 58: Japan exchange rate, 2018-23; Table 59: Russia generics market value: $ million, 2018-23; Table 60: Russia generics market volume: % of total pharma volume, 2018-23; Table 61: Russia generics market geography segmentation: $ million, 2023; Table 62: Russia generics market value forecast: $ million, 2023-28; Table 63: Russia generics market volume forecast: % of total pharma volume, 2023-28; Table 64: Russia Size of Population (million), 2019-23; Table 65: Russia real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 66: Russia GDP (Current Prices, $ Billion), 2019-23; Table 67: Russia Inflation, 2019-23; Table 68: Russia Consumer Price Index (Absolute), 2019-23; Table 69: Russia exchange rate, 2018-23; Table 70: United Kingdom generics market value: $ million, 2018-23; Table 71: United Kingdom generics market volume: % of total pharma volume, 2018-23; Table 72: United Kingdom generics market geography segmentation: $ million, 2023; Table 73: United Kingdom generics market value forecast: $ million, 2023-28; Table 74: United Kingdom generics market volume forecast: % of total pharma volume, 2023-28; Table 75: United Kingdom Size of Population (million), 2019-23; Table 76: United Kingdom real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 77: United Kingdom GDP (Current Prices, $ Billion), 2019-23; Table 78: United Kingdom Inflation, 2019-23; Table 79: United Kingdom Consumer Price Index (Absolute), 2019-23; Table 80: United Kingdom exchange rate, 2018-23; Table 81: United States generics market value: $ million, 2018-23; Table 82: United States generics market volume: % of total pharma volume, 2018-23; Table 83: United States generics market geography segmentation: $ million, 2023; Table 84: United States generics market value forecast: $ million, 2023-28; Table 85: United States generics market volume forecast: % of total pharma volume, 2023-28; Table 86: United States Size of Population (million), 2019-23; Table 87: United States real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 88: United States GDP (Current Prices, $ Billion), 2019-23; Table 89: United States Inflation, 2019-23; Table 90: United States Consumer Price Index (Absolute), 2019-23; Table 91: United States exchange rate, 2018-23; Table 92: Teva Pharmaceutical Industries Ltd: key facts; Table 93: Teva Pharmaceutical Industries Ltd: Annual Financial Ratios; Table 94: Teva Pharmaceutical Industries Ltd: Key Employees; Table 95: Viatris Inc: key facts; Table 96: Viatris Inc: Annual Financial Ratios; Table 97: Viatris Inc: Key Employees; Table 98: Sun Pharmaceutical Industries Ltd: key facts; Table 99: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios; Table 100: Sun Pharmaceutical Industries Ltd: Key Employees